4
Changes in Ownership
PULSE BIOSCIENCES, INC. Filed Acc 0001437749-26-004438
Chief Commercial Officer sold 60,000 shares at an average $23.51 ($1,410,600)
- Chief Commercial Officer acquired 60,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-12 | Option exercise 10b5-1 | +20,000 | $1.53 | $30,600 | 63,298 | D |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-12 | Sale 10b5-1 | −20,000 | $23.37 | $467,400 | 43,298 | D |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-13 | Option exercise 10b5-1 | +20,000 | $1.53 | $30,600 | 63,298 | D |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-13 | Sale 10b5-1 | −20,000 | $23.53 | $470,600 | 43,298 | D |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-17 | Option exercise 10b5-1 | +20,000 | $1.53 | $30,600 | 63,298 | D |
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-17 | Sale 10b5-1 | −20,000 | $23.63 | $472,600 | 43,298 | D |
| Derivatives | |||||||
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-12 | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 345,000 | D | ||
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-13 | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 325,000 | D | ||
| Danahy Kevin Patrick Chief Commercial Officer | 2026-02-17 | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 305,000 | D | ||
| Open-market sales · 60,000 sh · avg $23.51 · $1,410,600 | |||||||
Loading xslF345X05/rdgdoc.xml…